ASENTRA

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Romania

Active ingredients

The drug ASENTRA contains one active pharmaceutical ingredient (API):

1 Sertraline UNII UTI8907Y6X - SERTRALINE HYDROCHLORIDE

Sertraline is a potent and specific inhibitor of neuronal serotonin (5-HT) uptake in vitro, which results in the potentiation of the effects of 5-HT in animals. It has only very weak effects on norepinephrine and dopamine neuronal reuptake. Read about Sertraline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB06	Sertraline	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1013746, 1143100
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-681228481, HR-H-809836918
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003515, 1003516, 1088640
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100110576, 100110613, 100240758, 100468854
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W12873001, W12874001